| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/30/2011 | US8008496 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/30/2011 | US8008324 Antitumor agents; N-propargyl-N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indol-3-yl]glyoxylamide |
| 08/30/2011 | US8008306 Quinoline compounds |
| 08/30/2011 | US8008302 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis |
| 08/30/2011 | US8008297 Lysine based compounds |
| 08/30/2011 | CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 08/25/2011 | WO2011101424A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 08/25/2011 | US20110207935 Fused-ring derivative and medical application of same |
| 08/25/2011 | US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 08/25/2011 | US20110204354 Indenopyrene compound and organic light-emitting device using the compound |
| 08/25/2011 | CA2790643A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 08/24/2011 | EP2360147A1 Process for preparing crystalline particles of a salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-quinolinone (carmoterol) |
| 08/24/2011 | EP2359828A1 HDAC inhibitors and hormone targeted drugs for the treatment of cancer |
| 08/24/2011 | EP2358736A1 Therapeutic antiviral peptides |
| 08/24/2011 | EP2358680A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
| 08/24/2011 | EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 08/24/2011 | EP1375487B1 Process for producing quinoline-3-carboxylic acid compounds |
| 08/24/2011 | CN102164912A Process for making quinolone compounds |
| 08/24/2011 | CN102164897A Method for preparing montelukast sodium salts |
| 08/24/2011 | CN102162995A Photoresist composition |
| 08/24/2011 | CN101081834B Process for the preparation of leukotriene antagonists |
| 08/23/2011 | US8003791 Boronic ester and acid compounds, synthesis and uses |
| 08/23/2011 | US8003703 Phenoxiacetic acid derivatives |
| 08/23/2011 | US8003666 Hydrate for medical purposes |
| 08/23/2011 | US8003665 Salts and polymorphs of a potent antidiabetic compound |
| 08/23/2011 | US8003624 Functionally selective ALPHA2C adrenoreceptor agonists |
| 08/18/2011 | WO2011046991A3 Certain substituted ureas as modulators of kinase activity |
| 08/18/2011 | US20110201632 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists |
| 08/18/2011 | US20110201607 Fused heterocyclic m1 receptor positive allosteric modulators |
| 08/18/2011 | US20110200935 Photoresist composition |
| 08/18/2011 | US20110198774 Using of organic solvents in wet granulation of moxifloxacin |
| 08/17/2011 | EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them |
| 08/17/2011 | EP2357165A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders |
| 08/17/2011 | EP2356094A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists |
| 08/17/2011 | EP2355659A1 Fused heterocyclic m1 receptor positive allosteric modulators |
| 08/17/2011 | EP2222631B1 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 08/17/2011 | EP1644330B1 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | CN1910154B Quinoline derivatives for use as mycobacterial inhibitors |
| 08/17/2011 | CN102153570A Quick synthesis method of reverse-2-(2-hydroxy styryl)-8-oxyquinoline zinc |
| 08/17/2011 | CN102153512A Preparation method of rebamipide intermediate |
| 08/17/2011 | CN102153511A Industrial synthetic method for rubber antioxidant (RD) |
| 08/17/2011 | CN102153498A Resveratrol analogue and preparation method and application thereof |
| 08/17/2011 | CN102153463A 4-subsititued 3,5-dihydroxy carboxylic acid compound and preparation method thereof |
| 08/17/2011 | CN101045724B Coupling method for preparing quinolone intermediate |
| 08/16/2011 | US7999108 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 08/16/2011 | US7998980 Compounds for modulating TRPV3 function |
| 08/16/2011 | US7998979 Antibacterial quinoline derivatives |
| 08/16/2011 | CA2556653C Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 08/11/2011 | WO2011096461A1 Quinoline derivative |
| 08/11/2011 | WO2011095885A1 An improved process for the preparation of piperaquine |
| 08/11/2011 | WO2010143170A3 Compounds useful for treating premature aging and in particular progeria |
| 08/11/2011 | US20110195943 Napadisylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 08/11/2011 | US20110195066 Quinoline inhibitors of tyrosine kinase |
| 08/10/2011 | EP2354127A2 Solid acid catalyst and method for preparing and using the same |
| 08/10/2011 | EP2185519B1 Novel fungicides |
| 08/10/2011 | CN102149684A Process for producing 6-aryloxyquinoline derivative and intermediate therefor |
| 08/10/2011 | CN101429158B 2,4-diketone quinoline alkaloid, preparation and uses thereof |
| 08/09/2011 | US7994333 Methods and compositions for selectin inhibition |
| 08/09/2011 | US7994324 2-aminoquinoline derivatives |
| 08/09/2011 | US7994204 Binding inhibitor of sphingosine-1-phosphate |
| 08/09/2011 | US7994194 4-oxoquinoline derivatives |
| 08/09/2011 | US7994192 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections |
| 08/09/2011 | US7994165 Aryl aniline derivatives as β2 adrenergic receptor agonists |
| 08/09/2011 | US7994159 inhibits proliferation of c-Kit kinase activated-cancer; also mastocytosis, allergy and asthma, which are considered to be caused by c-Kit kinase; 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 08/09/2011 | CA2572208C 3-carbamoyl-2-pyridone derivative |
| 08/09/2011 | CA2539707C Quinoline potassium channel inhibitors |
| 08/09/2011 | CA2520990C A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones |
| 08/09/2011 | CA2451151C Carbamates of 2-heterocyclic-1,2-ethanediols |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 08/04/2011 | WO2011094708A2 Small molecules for the modulation of mcl-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders |
| 08/04/2011 | WO2011094260A2 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer |
| 08/04/2011 | WO2011093603A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/04/2011 | WO2010148209A3 Preparation of montelukast |
| 08/04/2011 | US20110190486 Sulfonamide derivatives of polycyclic dyes used for analytical applications |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110186831 Aromatic amine derivative and organic electroluminescence element using same |
| 08/04/2011 | CA2787784A1 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350014A1 Glycine b antagonists |
| 08/03/2011 | EP2350013A2 Compositions for labeling and identifying autophagosomes and methods for making and using them |
| 08/03/2011 | EP2350012A2 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders |
| 08/03/2011 | EP2350011A1 Methods of preparing quinoline derivatives |
| 08/03/2011 | EP1697326B1 Crystal form of quinoline compound and process for its production |
| 08/03/2011 | CN102143949A 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 08/03/2011 | CN102143942A Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors |
| 08/03/2011 | CN102140078A Improved scraup method for preparing quinoline or quinoline derivatives |
| 08/03/2011 | CN101582487B Organic electroluminescent device and display unit |
| 08/03/2011 | CN101511793B Antitumor agent for undifferentiated gastric cancer |
| 08/03/2011 | CN101316590B Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 08/02/2011 | US7989660 Bactericide against gramnegative bacteria; respiaratory system disorders |
| 08/02/2011 | US7989628 2-aminoquinolines |
| 08/02/2011 | US7989627 Optically active cyclic alcohol compound and method for preparing the same |
| 08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
| 08/02/2011 | US7989472 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 08/02/2011 | US7989453 Antitumor agents; for example, N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indole-3-yl]glyoxylamide |
| 08/02/2011 | CA2542796C Novel method of preparing 3-fluorinated quinolines |
| 08/02/2011 | CA2542105C Compounds and compositions as protein kinase inhibitors |
| 08/02/2011 | CA2537978C Substituted quinolines as protein tyrosine kinase enzyme inhibitors |